Potential for Recurrent Monkeypox Outbreaks, Nirmatrelvir/Ritonavir Receiving FDA Approval for Adult Patients at High Risk of Progression to Severe COVID-19, Efficacy and Safety of Antimicrobial Stewardship Prospective Audit and Feedback in Patients Hospitalized with COVID-19

0 views
August 2, 2023
Comments 0
Login to view comments. Click here to Login